Until Labs is developing reversible cryopreservation, a technology with the potential to redefine organ transplantation, IVF, and cancer treatment. But their previous brand didn’t reflect the scale or credibility of the science, making it harder to recruit top talent and communicate their healthcare vision.

We partnered with Until to strategically reposition the company, shifting them from “deep tech” to medical technology. The new identity brings clarity, trust, and human relevance to a field often misunderstood, giving the team a brand that supports hiring, strengthens clinical and investor conversations, and aligns with the company’s long-term ambitions.

The new site helped articulate the science with more clarity, align the brand with Until’s healthcare mission, and give the team a stronger platform to recruit, communicate, and grow.